The Crucial Findings Derived from the Special Issue "Inside Cancer Genomics: From Structure to Therapy"

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Jul 14

PMID 37444598

Authors

Vincenza Barresi

Affiliations

Soon will be listed here.

Abstract

Cancer initiation, growth, and progression are sustained by multiple types of genetic alterations, ranging in size from single point mutations, focal genomic errors to broad chromosomal copy number alterations, gains, and losses [...].

References

Barresi V, Di Bella V, Lo Nigro L, Privitera A, Bonaccorso P, Scuderi C . Temporary serine protease inhibition and the role of SPINK2 in human bone marrow. iScience. 2023; 26(6):106949. PMC: 10291479. DOI: 10.1016/j.isci.2023.106949. View

Davoli T, Uno H, Wooten E, Elledge S . Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science. 2017; 355(6322). PMC: 5592794. DOI: 10.1126/science.aaf8399. View

. Pan-cancer analysis of whole genomes. Nature. 2020; 578(7793):82-93. PMC: 7025898. DOI: 10.1038/s41586-020-1969-6. View

Wong J, Aichmuller C, Schulze M, Hlevnjak M, Elgaafary S, Lichter P . Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions. Nat Commun. 2022; 13(1):178. PMC: 8748499. DOI: 10.1038/s41467-021-27792-6. View

Rubinstein T, Reuveni I, Hesin A, Klein-Goldberg A, Olauson H, Larsson T . A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy. Cancers (Basel). 2021; 13(24). PMC: 8699737. DOI: 10.3390/cancers13246297. View

Fisher R, Pusztai L, Swanton C . Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. 2013; 108(3):479-85. PMC: 3593543. DOI: 10.1038/bjc.2012.581. View

Vadakekolathu J, Boocock D, Pandey K, Guinn B, Legrand A, Miles A . Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy. Cancers (Basel). 2022; 14(16). PMC: 9406384. DOI: 10.3390/cancers14163975. View

Mattick J, Amaral P, Carninci P, Carpenter S, Chang H, Chen L . Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023; 24(6):430-447. PMC: 10213152. DOI: 10.1038/s41580-022-00566-8. View

Privitera A, Barresi V, Condorelli D . Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes. Cancers (Basel). 2021; 13(7). PMC: 8037453. DOI: 10.3390/cancers13071585. View

10.

Condorelli D, Privitera A, Barresi V . Chromosomal Density of Cancer Up-Regulated Genes, Aberrant Enhancer Activity and Cancer Fitness Genes Are Associated with Transcriptional Cis-Effects of Broad Copy Number Gains in Colorectal Cancer. Int J Mol Sci. 2019; 20(18). PMC: 6770609. DOI: 10.3390/ijms20184652. View

11.

Qu X, Zhang Y, Sang X, Ren D, Zhao H, Wong S . Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer. Cancers (Basel). 2022; 14(13). PMC: 9264946. DOI: 10.3390/cancers14133195. View

12.

Kuo M, Fu S, Savaraj N, Chen H . Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy. Cancer Res. 2012; 72(18):4616-21. PMC: 3445735. DOI: 10.1158/0008-5472.CAN-12-0888. View

13.

Taylor A, Shih J, Ha G, Gao G, Zhang X, Berger A . Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell. 2018; 33(4):676-689.e3. PMC: 6028190. DOI: 10.1016/j.ccell.2018.03.007. View

14.

Oparina N, Erlandsson M, Faldt Beding A, Parris T, Helou K, Karlsson P . Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts. Cancers (Basel). 2021; 13(9). PMC: 8125570. DOI: 10.3390/cancers13092209. View

15.

Ishida S, McCormick F, Smith-McCune K, Hanahan D . Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell. 2010; 17(6):574-83. PMC: 2902369. DOI: 10.1016/j.ccr.2010.04.011. View

16.

Barresi V, Castorina S, Musso N, Capizzi C, Luca T, Privitera G . Chromosomal instability analysis and regional tumor heterogeneity in colon cancer. Cancer Genet. 2017; 210:9-21. DOI: 10.1016/j.cancergen.2016.11.001. View

17.

Ben-David U, Amon A . Context is everything: aneuploidy in cancer. Nat Rev Genet. 2019; 21(1):44-62. DOI: 10.1038/s41576-019-0171-x. View

18.

Cetraro P, Plaza-Diaz J, Mackenzie A, Abadia-Molina F . A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer. Cancers (Basel). 2022; 14(7). PMC: 8996962. DOI: 10.3390/cancers14071671. View

19.

Hu N, Wang C, Zhang T, Su H, Liu H, Yang H . Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma. Cancers (Basel). 2022; 14(20). PMC: 9599939. DOI: 10.3390/cancers14205001. View

20.

Condorelli D, Spampinato G, Valenti G, Musso N, Castorina S, Barresi V . Positive Caricature Transcriptomic Effects Associated with Broad Genomic Aberrations in Colorectal Cancer. Sci Rep. 2018; 8(1):14826. PMC: 6172234. DOI: 10.1038/s41598-018-32884-3. View